Who
Ngar Yee Louie
Director
Company insider
Files Form 4 as: Director, MAIA Biotechnology.
In numbers
- Trades disclosed
- 27
- Buys
- 5
- Sells
- 0
- Bought
- $548K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 1 Aug 2022
- Last trade
- 30 Sep 2026
- Last filed
- 2 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 30 Sep 2026filed 2 Oct 2026 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —39,634 at $0.00 | filing |
| 30 Jun 2026filed 2 Jul 2026 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —32,630 at $0.00 | filing |
| 30 Jun 2026filed 2 Jul 2026 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —32,630 at $0.00 | filing |
| 31 Mar 2026filed 2 Apr 2026 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —33,748 at $0.00 | filing |
| 31 Mar 2026filed 2 Apr 2026 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —33,748 at $0.00 | filing |
| 31 Dec 2025filed 5 Jan 2026 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —29,789 at $0.00 | filing |
| 31 Dec 2025filed 5 Jan 2026 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —29,789 at $0.00 | filing |
| 22 Dec 2025filed 23 Dec 2025 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code P | $111K81,699 at $1.36 | filing |
| 22 Dec 2025filed 23 Dec 2025 | MAIA MAIA BiotechnologyBiotechnology | SEC FORM 4 Bought | $100K81,699 at $1.22 | filing |
| 2 Oct 2025filed 6 Oct 2025 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,331 at $0.00 | filing |
| 30 Jun 2025filed 2 Jul 2025 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,232 at $0.00 | filing |
| 4 Apr 2025filed 8 Apr 2025 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —26,304 at $0.00 | filing |
| 31 Dec 2024filed 3 Jan 2025 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,338 at $0.00 | filing |
| 30 Sep 2024filed 2 Oct 2024 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,848 at $0.00 | filing |
| 30 Jun 2024filed 2 Jul 2024 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,592 at $0.00 | filing |
| 25 Apr 2024filed 26 Apr 2024 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code P | $44K19,665 at $2.26 | filing |
| 25 Apr 2024filed 26 Apr 2024 | MAIA MAIA BiotechnologyBiotechnology | SEC FORM 4 Bought | $40K19,665 at $2.03 | filing |
| 31 Mar 2024filed 2 Apr 2024 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —13,790 at $0.00 | filing |
| 14 Mar 2024filed 15 Mar 2024 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code P | $222K170,940 at $1.30 | filing |
| 14 Mar 2024filed 15 Mar 2024 | MAIA MAIA BiotechnologyBiotechnology | SEC FORM 4 Bought | $200K170,940 at $1.17 | filing |
News
MAIA Biotechnology (NYSEAMERICAN:MAIA) Shares Up 0.8% – Here's What HappenedMAIA · dailypolitical.com · 8 Oct 2026MAIA Biotechnology Achieves Patient Enrollment Milestones in Ongoing Phase 2 and Pivotal Phase 3 Clinical Trials in Non-Small Cell Lung CancerMAIA · manilatimes.net · 7 Oct 2026
0 headlines in the last 90 days name Ngar Yee Louie; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.